Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Pediatric Endocrinology Reviews : PER
|
May 17, 2017
Endocrine Disorders Developing after Surgical Intervention of Craniopharyngioma in Children
Kyrillus S Shohdy, Wegdan Rashad
Therapeutic Delivery
|
September 13, 2013
Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions
Kyrillus S Shohdy, Ahmad Samir Alfaar
Endocrine, Metabolic & Immune Disorders Drug Targets
|
November 24, 2015
GPR 120: The Potential Target for Obesity Treatment
Peter A Tanagho, Kyrillus S Shohdy
Middle East Journal of Digestive Diseases
|
April 24, 2018
Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
Kyrillus S Shohdy, Wegdan Rashad, Ahmed Elmeligui
Current Medical Research and Opinion
|
March 2, 2018
Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy
Loay Kassem, Kyrillus S Shohdy, Omar Abdel-Rahman
Cancer Investigation
|
January 25, 2020
Safety of Combination Immune Checkpoint Inhibitors Compared to Monotherapy; A Systematic Review and Meta-Analysis
Ahmed A M Abdelhafeez, Kyrillus S Shohdy, Wael Ibrahim
Cancer Immunology, Immunotherapy : CII
|
October 31, 2022
Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis
Kathryn Owen, Ramy Ghaly, Kyrillus S Shohdy, et al.
Expert Review of Anticancer Therapy
|
July 13, 2017
Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
Shaimaa Lasheen, Kyrillus S Shohdy, Loay Kassem, et al.
Cancer Reports (Hoboken, N.J.)
|
July 2, 2026
Advancing Cancer Cachexia Drug Development: Leveraging Biomarkers and Functional Endpoints to Optimize Trial Design
Nada O Othman, Hadir Habib, Doaa M Almeldin, et al.
Therapeutic Advances in Drug Safety
|
November 2, 2017
Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis
Kyrillus S Shohdy, Shaimaa Lasheen, Loay Kassem, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Pediatric Endocrinology Reviews : PER
|
May 17, 2017
Endocrine Disorders Developing after Surgical Intervention of Craniopharyngioma in Children
Kyrillus S Shohdy, Wegdan Rashad
Therapeutic Delivery
|
September 13, 2013
Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions
Kyrillus S Shohdy, Ahmad Samir Alfaar
Endocrine, Metabolic & Immune Disorders Drug Targets
|
November 24, 2015
GPR 120: The Potential Target for Obesity Treatment
Peter A Tanagho, Kyrillus S Shohdy
Middle East Journal of Digestive Diseases
|
April 24, 2018
Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
Kyrillus S Shohdy, Wegdan Rashad, Ahmed Elmeligui
Current Medical Research and Opinion
|
March 2, 2018
Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy
Loay Kassem, Kyrillus S Shohdy, Omar Abdel-Rahman
Cancer Investigation
|
January 25, 2020
Safety of Combination Immune Checkpoint Inhibitors Compared to Monotherapy; A Systematic Review and Meta-Analysis
Ahmed A M Abdelhafeez, Kyrillus S Shohdy, Wael Ibrahim
Cancer Immunology, Immunotherapy : CII
|
October 31, 2022
Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis
Kathryn Owen, Ramy Ghaly, Kyrillus S Shohdy, et al.
Expert Review of Anticancer Therapy
|
July 13, 2017
Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
Shaimaa Lasheen, Kyrillus S Shohdy, Loay Kassem, et al.
Cancer Reports (Hoboken, N.J.)
|
July 2, 2026
Advancing Cancer Cachexia Drug Development: Leveraging Biomarkers and Functional Endpoints to Optimize Trial Design
Nada O Othman, Hadir Habib, Doaa M Almeldin, et al.
Therapeutic Advances in Drug Safety
|
November 2, 2017
Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis
Kyrillus S Shohdy, Shaimaa Lasheen, Loay Kassem, et al.
Page
of 4